Civic Intelligence

End Kids Cancer

EIN 90-0648733 • 501(c)3 • San Luis Obispo, CA

Profile

To support research and clinical trials that will cure neurobastoma with an emphasis on non-toxic treatments.

1150 Fuller RoadSan Luis Obispo, CA 93401

www.endkidscancer.org

Siviq Scores

Precomputed percentiles relative to similar nonprofits. These scores are descriptive rather than judgmental.

Liabilities / Assets

75th percentile

0.05x

Higher debt load relative to assets than 75% of similar nonprofits.

501(c)3 • <$500k nonprofits • Source year 2024

Liabilities / Revenue

78th percentile

0.05x

Higher debt load relative to revenue than 78% of similar nonprofits.

501(c)3 • <$500k nonprofits • Source year 2024

Net Margin

86th percentile

39%

Higher net margin than 86% of similar nonprofits.

501(c)3 • <$500k nonprofits • Source year 2024

Top Officer Pay

90th percentile

$30,000

Higher top officer pay than 90% of similar nonprofits.

Top officer pay equals 41.1% of source-year revenue.

501(c)3 • <$500k nonprofits • Source year 2024

Asset Growth

90th percentile

76%

Faster asset growth than 90% of similar nonprofits.

501(c)3 • <$500k nonprofits • Annualized from 2023 to 2024

Revenue Growth

37th percentile

-16%

Faster revenue growth than 37% of similar nonprofits.

501(c)3 • <$500k nonprofits • Annualized from 2023 to 2024

Assets

Up

$65,445

Up $28,342 (+76%) from 2023

Liabilities

Down

$3,387

Down $466 (-12%) from 2023

Net Assets

$62,058

No earlier filing loaded for comparison.

Revenue

Down

$73,018

Down $13,561 (-16%) from 2023

Expenses

Down

$44,210

Down $35,849 (-45%) from 2023

Net Income

Up

$28,808

Up $22,288 (+342%) from 2023

Trend Graphs

Balance Sheet Trend

Grouped bars show assets, liabilities, and net assets across loaded filings.

$150K$100K$50K$0Assets 2011: $20,796Liabilities 2011: $392Net Assets 2011: $20,4042011Assets 2012: $25,141Liabilities 2012: $0Net Assets 2012: $25,1412012Assets 2013: $29,136Liabilities 2013: $0Net Assets 2013: $29,1362013Assets 2014: $41,923Liabilities 2014: $1,027Net Assets 2014: $40,8962014Assets 2015: $92,704Liabilities 2015: $2,292Net Assets 2015: $90,4122015Assets 2016: $130,640Liabilities 2016: $5,587Net Assets 2016: $125,0532016Assets 2017: $63,783Liabilities 2017: $2,0342017Assets 2018: $39,545Liabilities 2018: $3,902Net Assets 2018: $35,6432018Assets 2019: $42,092Liabilities 2019: $3,291Net Assets 2019: $38,8012019Assets 2020: $28,005Liabilities 2020: $2,442Net Assets 2020: $25,5632020Assets 2021: $53,255Liabilities 2021: $4,3732021Assets 2022: $31,209Liabilities 2022: $4,479Net Assets 2022: $26,7302022Assets 2023: $37,103Liabilities 2023: $3,8532023Assets 2024: $65,445Liabilities 2024: $3,387Net Assets 2024: $62,0582024

Highlighted filing

2024

Assets$65,445
Liabilities$3,387
Net Assets$62,058

Operations Trend

Revenue, expenses, and net income by year, with the latest filing highlighted.

$200K$100K$0-$100KRevenue 2011: $82,197Expenses 2011: $67,041Net Income 2011: $15,1562011Revenue 2012: $58,363Expenses 2012: $53,626Net Income 2012: $4,7372012Revenue 2013: $40,822Expenses 2013: $36,827Net Income 2013: $3,9952013Revenue 2014: $143,679Expenses 2014: $131,919Net Income 2014: $11,7602014Revenue 2015: $99,988Expenses 2015: $50,472Net Income 2015: $49,5162015Revenue 2016: $102,937Expenses 2016: $68,296Net Income 2016: $34,6412016Revenue 2017: $39,713Expenses 2017: $103,017Net Income 2017: -$63,3042017Revenue 2018: $103,868Expenses 2018: $129,974Net Income 2018: -$26,1062018Revenue 2019: $103,258Expenses 2019: $100,100Net Income 2019: $3,1582019Revenue 2020: $37,623Expenses 2020: $50,860Net Income 2020: -$13,2372020Revenue 2021: $110,723Expenses 2021: $87,404Net Income 2021: $23,3192021Revenue 2022: $32,506Expenses 2022: $54,658Net Income 2022: -$22,1522022Revenue 2023: $86,579Expenses 2023: $80,059Net Income 2023: $6,5202023Revenue 2024: $73,018Expenses 2024: $44,210Net Income 2024: $28,8082024

Highlighted filing

2024

Revenue$73,018
Expenses$44,210
Net Income$28,808

Filings

Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2024Detailed filing. Detailed filing data is available for this year.$0.65$0.03$0.62$0.73$0.44$0.29
2023Summary only. Only limited summary data is available for this year.$0.37$0.04$0.87$0.80$0.07
2022Detailed filing. Detailed filing data is available for this year.$0.31$0.04$0.27$0.33$0.55$0.22
2021Summary only. Only limited summary data is available for this year.$0.53$0.04$1.11$0.87$0.23
2020Detailed filing. Detailed filing data is available for this year.$0.28$0.02$0.26$0.38$0.51$0.13
2019XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$0.42$0.03$0.39$1.03$1.00$0.03
2018XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$0.40$0.04$0.36$1.04$1.30$0.26
2017Summary only. Only limited summary data is available for this year.$0.64$0.02$0.40$1.03$0.63
2016XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$1.31$0.06$1.25$1.03$0.68$0.35
2015Detailed filing. Detailed filing data is available for this year.$0.93$0.02$0.90$1.00$0.50$0.50
2014Detailed filing. Detailed filing data is available for this year.$0.42$0.01$0.41$1.44$1.32$0.12
2013Detailed filing. Detailed filing data is available for this year.$0.29$0.00$0.29$0.41$0.37$0.04
2012Facts available. Structured filing facts are available, but richer extracted sections are limited.$0.25$0.00$0.25$0.58$0.54$0.05
2011Facts available. Structured filing facts are available, but richer extracted sections are limited.$0.21$0.00$0.20$0.82$0.67$0.15
Latest Filing Detail
Jump To
Filing Snapshot
Filing Period
Jan 1, 2024 to Dec 31, 2024
Signed
Nov 7, 2025
Return Version
2024v5.2
Gross Receipts
$73,018
Mission and Program Overview

Mission

To support research and clinical trials that will cure neuroblastoma with an emphasis on non-toxic treatments.

To support research and clinical trials that will cure neurobastoma with an emphasis on non-toxic treatments.

Program Services

DescriptionGrantsExpenses
PUBLIC AWARENESS AND FINANCIAL SUPPORT FOR RESEARCH AND CLINICAL TRIALS THAT WILL CURE NEUROBLASTOMA. LIQUID BIOPSY AND BIVALENT VACCINE TRIALS CONDUCTED AT MEMORIAL SLOAN-KETTERING CANCER CENTER.$0$44,209
Compensation and Service Providers

Employees

NameTitleFull / Part TimeBaseOtherTotal
FRANK KALMANPresidentFT$30,000-$30,000
TERRY KALMANDirector-$0--
TAYLOR FUKUSHIMATreasurer-$0--
GUY RATHBUNDirector-$0--
DAN ROBERTSDirector-$0--
Filing and Contact Details

Filer

Filer Name
End Kids Cancer
EIN
90-0648733
Phone
8055507682
Address
1150 FULLER ROAD, SAN LUIS OBISPO, CA 93401

Signing Officer

Name
Frank Kalman
Title
President
Phone
8055507682
Signed
2025-11-07
Discuss with paid preparer
Yes

Preparer

Firm
Longcrier & Associates Cpas Llp
Address
100 CROSS ST SUITE 103, SAN LUIS OBISPO, CA 93401-7570
Preparer
Jayme Phillips
Phone
8055412500
Supplemental Narrative

Additional Explanations

Form 990-ez, Part I, Line 16 - Other Expenses

Description: business registration fees. Amount: 20. Description: supplies. Amount: 515. Description: computer expense. Amount: 2,428. Description: telephone. Amount: 1,298. Description: advertising. Amount: 1,000. Description: dues. Amount: 341. Description: insurance. Amount: 737. Description: website. Amount: 442. Description: travel. Amount: 2,186. Description: miscellaneous. Amount: 166. Description: taxes. Amount: 50. Total to form 990-ez, line 16: 9,183.

Form 990-ez, Part II, Line 26 - Other Liabilities

Description: payroll liabilities. Beg. Of year amount: 2,074. End of year amount: 2,074. Description: reimbursement payable. Beg. Of year amount: 1,779. End of year amount: 1,313.

Raw XML Appendix157 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990EZ/ActivitiesNotPreviouslyRptInd00
IRS990EZ/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt0TERRY J KALMAN
IRS990EZ/BooksInCareOfDetail/PhoneNum08055507682
IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine1Txt01150 FULLER ROAD
IRS990EZ/BooksInCareOfDetail/USAddress/CityNm0SAN LUIS OBISPO
IRS990EZ/BooksInCareOfDetail/USAddress/StateAbbreviationCd0CA
IRS990EZ/BooksInCareOfDetail/USAddress/ZIPCd093401
IRS990EZ/CashSavingsAndInvestmentsGrp/BOYAmt037103
IRS990EZ/CashSavingsAndInvestmentsGrp/EOYAmt065445
IRS990EZ/ChgMadeToOrgnzngDocNotRptInd00
IRS990EZ/ContributionsGiftsGrantsEtcAmt073018
IRS990EZ/DirectIndirectPltclExpendAmt00
IRS990EZ/DonorAdvisedFndsInd00
IRS990EZ/EngagedInExcessBenefitTransInd00
IRS990EZ/ExcessOrDeficitForYearAmt028808
IRS990EZ/FeesAndOtherPymtToIndCntrctAmt0575
IRS990EZ/FiledScheduleAInd01
IRS990EZ/ForeignFinancialAccountInd00
IRS990EZ/ForeignOfficeInd00
IRS990EZ/Form990TotalAssetsGrp/BOYAmt037103
IRS990EZ/Form990TotalAssetsGrp/EOYAmt065445
IRS990EZ/GrossReceiptsAmt073018
IRS990EZ/InfoInScheduleOPartIIIInd0X
IRS990EZ/InfoInScheduleOPartIIInd0X
IRS990EZ/InfoInScheduleOPartIInd0X
IRS990EZ/InfoInScheduleOPartVInd0X
IRS990EZ/LobbyingActivitiesInd00
IRS990EZ/MadeLoansToFromOfficersInd00
IRS990EZ/MethodOfAccountingCashInd0X
IRS990EZ/NetAssetsOrFundBalancesBOYAmt033250
IRS990EZ/NetAssetsOrFundBalancesEOYAmt062058
IRS990EZ/NetAssetsOrFundBalancesGrp/BOYAmt033250
IRS990EZ/NetAssetsOrFundBalancesGrp/EOYAmt062058
IRS990EZ/OccupancyRentUtltsAndMaintAmt0935
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt060.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt12.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt22.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt32.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt42.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt030000
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt40
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt40
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt40
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm0FRANK KALMAN
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm1TERRY KALMAN
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm2TAYLOR FUKUSHIMA
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm3GUY RATHBUN
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm4DAN ROBERTS
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt0PRESIDENT
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt1DIRECTOR
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt2TREASURER
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt3DIRECTOR
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt4DIRECTOR
IRS990EZ/OperateHospitalInd00
IRS990EZ/Organization501c3Ind0X
IRS990EZ/OrganizationDissolvedEtcInd00
IRS990EZ/OrganizationHadUBIInd00
IRS990EZ/OtherChangesInNetAssetsAmt00
IRS990EZ/OtherExpensesTotalAmt09183
IRS990EZ/PartVIHghstPdCntrctProfSrvcTxt0NONE
IRS990EZ/PartVIOfCompOfHghstPdEmplTxt0NONE
IRS990EZ/PoliticalCampaignActyInd00
IRS990EZ/PrimaryExemptPurposeTxt0TO SUPPORT RESEARCH AND CLINICAL TRIALS THAT WILL CURE NEUROBASTOMA WITH AN EMPHASIS ON NON-TOXIC TREATMENTS.
IRS990EZ/PrintingPublicationsPostageAmt01110
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt0PUBLIC AWARENESS AND FINANCIAL SUPPORT FOR RESEARCH AND CLINICAL TRIALS THAT WILL CURE NEUROBLASTOMA. LIQUID BIOPSY AND BIVALENT VACCINE TRIALS CONDUCTED AT MEMORIAL SLOAN-KETTERING CANCER CENTER.
IRS990EZ/ProgramSrvcAccomplishmentGrp/GrantsAndAllocationsAmt00
IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt044209
IRS990EZ/ProhibitedTaxShelterTransInd00
IRS990EZ/RelatedOrganizationCtrlEntInd00
IRS990EZ/SalariesOtherCompEmplBnftAmt032407
IRS990EZ/SchoolOperatingInd00
IRS990EZ/StatesWhereCopyOfReturnIsFldCd0CA
IRS990EZ/SubjectToProxyTaxInd00
IRS990EZ/SumOfTotalLiabilitiesGrp/BOYAmt03853
IRS990EZ/SumOfTotalLiabilitiesGrp/EOYAmt03387
IRS990EZ/TanningServicesProvidedInd00
IRS990EZ/TaxImposedOnOrganizationMgrAmt00
IRS990EZ/TaxImposedUnderIRC4911Amt00
IRS990EZ/TaxImposedUnderIRC4912Amt00
IRS990EZ/TaxImposedUnderIRC4955Amt00
IRS990EZ/TaxReimbursedByOrganizationAmt00
IRS990EZ/TotalExpensesAmt044210
IRS990EZ/TotalProgramServiceExpensesAmt044209
IRS990EZ/TotalRevenueAmt073018
IRS990EZ/TrnsfrExmptNonChrtblRltdOrgInd00
IRS990EZ/TypeOfOrganizationCorpInd0X
IRS990EZ/WebsiteAddressTxt0WWW.ENDKIDSCANCER.ORG
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearAmt073018
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus1YearAmt086579
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus2YearsAmt032506
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus3YearsAmt087223
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus4YearsAmt037622
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/TotalAmt0316948
IRS990ScheduleA/PublicOrganization170Ind0X
IRS990ScheduleA/PublicSupportCY170Pct01.00000
IRS990ScheduleA/PublicSupportPY170Pct00.87150
IRS990ScheduleA/PublicSupportTotal170Amt0316948
IRS990ScheduleA/ThirtyThrPctSuprtTestsCY170Ind0X
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearAmt073018
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus1YearAmt086579
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus2YearsAmt032506
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus3YearsAmt087223
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus4YearsAmt037622
IRS990ScheduleA/TotalCalendarYear170Grp/TotalAmt0316948
IRS990ScheduleA/TotalSupportAmt0316948
IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorNum0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine20RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt0RESTRICTED
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0DESCRIPTION: BUSINESS REGISTRATION FEES. AMOUNT: 20. DESCRIPTION: SUPPLIES. AMOUNT: 515. DESCRIPTION: COMPUTER EXPENSE. AMOUNT: 2,428. DESCRIPTION: TELEPHONE. AMOUNT: 1,298. DESCRIPTION: ADVERTISING. AMOUNT: 1,000. DESCRIPTION: DUES. AMOUNT: 341. DESCRIPTION: INSURANCE. AMOUNT: 737. DESCRIPTION: WEBSITE. AMOUNT: 442. DESCRIPTION: TRAVEL. AMOUNT: 2,186. DESCRIPTION: MISCELLANEOUS. AMOUNT: 166. DESCRIPTION: TAXES. AMOUNT: 50. TOTAL TO FORM 990-EZ, LINE 16: 9,183.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1DESCRIPTION: PAYROLL LIABILITIES. BEG. OF YEAR AMOUNT: 2,074. END OF YEAR AMOUNT: 2,074. DESCRIPTION: REIMBURSEMENT PAYABLE. BEG. OF YEAR AMOUNT: 1,779. END OF YEAR AMOUNT: 1,313.
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0FORM 990-EZ, PART I, LINE 16 - OTHER EXPENSES
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1FORM 990-EZ, PART II, LINE 26 - OTHER LIABILITIES
TransferPrsnlBnftContractsDecl/DeclarationDesc0THE ORGANIZATION DID NOT, DURING THE YEAR, RECEIVE ANY FUNDS, DIRECTLY,OR INDIRECTLY, TO PAY PREMIUMS ON A PERSONAL BENEFIT CONTRACT.THE ORGANIZATION, DID NOT, DURING THE YEAR, PAY ANY PREMIUMS, DIRECTLY,OR INDIRECTLY, ON A PERSONAL BENEFIT CONTRACT.
ReturnHeader/BuildTS02025-03-06 01:10:19Z
ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd01
ReturnHeader/BusinessOfficerGrp/PersonNm0FRANK KALMAN
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0PRESIDENT
ReturnHeader/BusinessOfficerGrp/PhoneNum08055507682
ReturnHeader/BusinessOfficerGrp/SignatureDt02025-11-07
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0END KIDS CANCER
ReturnHeader/Filer/BusinessNameControlTxt0ENDK
ReturnHeader/Filer/EIN0900648733
ReturnHeader/Filer/PhoneNum08055507682
ReturnHeader/Filer/USAddress/AddressLine1Txt01150 FULLER ROAD
ReturnHeader/Filer/USAddress/CityNm0SAN LUIS OBISPO
ReturnHeader/Filer/USAddress/StateAbbreviationCd0CA
ReturnHeader/Filer/USAddress/ZIPCd093401
ReturnHeader/IRSResponsiblePrtyInfoCurrInd01
ReturnHeader/PreparerFirmGrp/PreparerFirmEIN0810718703
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt0LONGCRIER & ASSOCIATES CPAS LLP
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt0100 CROSS ST SUITE 103
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm0SAN LUIS OBISPO
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd0CA
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd0934017570
ReturnHeader/PreparerPersonGrp/PhoneNum08055412500
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0JAYME PHILLIPS
ReturnHeader/ReturnTs02025-11-12T12:32:55-06:00
ReturnHeader/ReturnTypeCd0990EZ
ReturnHeader/TaxPeriodBeginDt02024-01-01
ReturnHeader/TaxPeriodEndDt02024-12-31
ReturnHeader/TaxYr02024

Document Assets

No mirrored PDF or thumbnail assets are attached yet.